Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome Gefitinib-resistance in non-small cell lung cancer cell lines
- Resource Type
- Article
- Source
- In
Advances in Medical Sciences 1 December 2011 56(2):275-284 - Subject
- Language
- ISSN
- 1896-1126